After 20 days of oral vancomycin therapy, should I repeat stool testing for Clostridioides difficile toxin or PCR due to loose stools?

Do Not Retest for C. difficile After Completing Vancomycin Treatment

You should NOT repeat stool testing for C. difficile toxin or PCR after completing 20 days of oral vancomycin therapy, even if you still have loose stools. This is a test-of-cure scenario, which is explicitly discouraged in clinical practice.

Why Testing is Not Recommended

The presence of loose stools after vancomycin treatment does not automatically indicate treatment failure or active infection. Here's the clinical reasoning:

Post-Treatment Stool Patterns Are Expected

• C. difficile organisms commonly persist in stool during and after vancomycin therapy without causing active disease 1. Clinical trials show that approximately 50% of successfully treated patients continue to have C. difficile detected in their stools for weeks after completing therapy 2.

• The median time to diarrhea resolution is 4-5 days during treatment, but some patients (especially those >65 years) may take up to 6 days 1. After 20 days of treatment, you're well beyond the expected resolution timeframe.

• Recurrence rates are 18-23% in successfully treated patients 1, typically occurring 4-21 days after stopping vancomycin 3.

The Testing Trap

Retesting creates a diagnostic dilemma because:

• NAAT (PCR) tests remain positive for weeks to months after successful treatment due to persistent colonization 4
• A positive test does not distinguish between active infection and asymptomatic colonization
• This leads to unnecessary retreatment and antibiotic exposure

What You Should Do Instead

Clinical Assessment is Key

Evaluate for true CDI recurrence based on symptoms, not testing:

• Active CDI requires: ≥3 loose/watery stools in 24 hours PLUS systemic symptoms (abdominal pain, fever, leukocytosis)
• Loose stools alone, without toxin-mediated symptoms, suggest post-infectious changes or colonization

If This is True Recurrence (Symptomatic)

Based on 2021 IDSA/SHEA guidelines 5:

For first recurrence after initial episode:

• Preferred: Fidaxomicin 200 mg twice daily for 10 days
• Alternative: Vancomycin in tapered/pulsed regimen (125 mg QID × 10-14 days, then BID × 7 days, then daily × 7 days, then every 2-3 days × 2-8 weeks)
• Alternative: Standard vancomycin 125 mg QID × 10 days (if metronidazole was used initially)

If Asymptomatic or Minimal Symptoms

• Do not treat asymptomatic C. difficile carriage 6. Treatment of asymptomatic carriers does not provide long-term clearance and increases VRE colonization risk.
• Consider post-infectious irritable bowel syndrome or microbiome disruption as alternative explanations for loose stools

Important Caveats

Risk of Vancomycin-Resistant Enterococci (VRE)

Extended vancomycin use carries significant risks:

• VRE colonization occurs in 50% of patients treated with oral vancomycin versus 24% with placebo 4
• This increases environmental contamination and transmission risk 4

The 20-Day Duration Concern

Standard CDI treatment is 10 days 5. If you've been on vancomycin for 20 days:

• This suggests either a tapered/pulsed regimen for recurrent CDI, or
• Potentially inappropriate extended treatment duration

If this was continuous daily dosing for 20 days (not a tapered regimen), this is longer than guideline-recommended and increases adverse effects without additional benefit.

Bottom Line Algorithm

1. Are symptoms consistent with active CDI? (≥3 watery stools/day + abdominal pain/fever/leukocytosis)

   • NO: Do not test, do not treat. Monitor clinically.
   • YES: Proceed to step 2.

2. Is this a first recurrence or subsequent recurrence?

   • First recurrence: Use fidaxomicin or tapered vancomycin per guidelines 5
   • Second+ recurrence: Consider FMT after appropriate antibiotic trials 5

3. Never use test results to guide treatment decisions in the post-treatment period.